Karen Bush
- Molecular Medicine top 0.01%
- Pharmacology top 0.02%
- Molecular Biology top 1%
- Endocrinology top 0.01%
- Epidemiology top 0.5%
- Co-authors
- George A. JacobyAnne Marie QueenanPatricia A. BradfordAntone A. MedeirosB A RasmussenMark J. MacielagR. B. SykesDarren Abbanat
- Topics
- Antibiotic Resistance in Bacteria (150 papers)Antibiotics Pharmacokinetics and Efficacy (81 papers)Antimicrobial Resistance in Staphylococcus (39 papers)
- Partner nations
- United StatesMalaysiaSwitzerland
In The Last Decade
Karen Bush
217 papers receiving 21.7k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Molecular Medicine 17.4k
- Pharmacology 7.3k
- Molecular Biology 5.8k
- Endocrinology 5.5k
- Epidemiology 4.3k
Countries citing papers authored by Karen Bush
This map shows the geographic impact of Karen Bush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Bush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Bush more than expected).
Fields of papers citing papers by Karen Bush
This network shows the impact of papers produced by Karen Bush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Bush. The network helps show where Karen Bush may publish in the future.
Co-authorship network of co-authors of Karen Bush
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Bush. A scholar is included among the top collaborators of Karen Bush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Bush. Karen Bush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 16 | |
| 6 | Critical analysis of antibacterial agents in clinical developmentbreakdown → | 268 |
| 7 | 6 | |
| 8 | 81 | |
| 9 | 43 | |
| 10 | 2 | |
| 11 | 122 | |
| 12 | 37 | |
| 13 | 10 | |
| 14 | 98 | |
| 15 | Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferasebreakdown → | 750 |
| 16 | 87 | |
| 17 | 37 | |
| 18 | 110 | |
| 19 | 25 | |
| 20 | 13 |
About Karen Bush
Karen Bush is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 218 papers that have together received 22.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (150 papers), Antibiotics Pharmacokinetics and Efficacy (81 papers) and Antimicrobial Resistance in Staphylococcus (39 papers). The work is most often cited by research in Molecular Medicine (17.4k citations), Applied Microbiology and Biotechnology (3.0k citations) and Endocrinology (5.5k citations). Karen Bush has collaborated with scholars based in United States, Malaysia and Switzerland. Frequent co-authors include George A. Jacoby, Anne Marie Queenan, Patricia A. Bradford, Antone A. Medeiros, B A Rasmussen, Mark J. Macielag, R. B. Sykes, Darren Abbanat, George M. Eliopoulos and James W. Biddle. Their work appears in journals such as Nature, Science and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.